Jenrin Discovery (United States)

Statistics

Publications

Citations

1.2K

Authors

Location

West Chester, United States

Jenrin Discovery (United States) is a company institution in West Chester, United States known for medicine, pharmacology, and molecular pharmacology.

Homepage ROR

Top concepts

MedicinePharmacologyMetabolic SyndromeCannabinoid PharmacologyMolecular PharmacologyPharmacotherapyNeuropharmacologyNeurotransmissionEndocannabinoid SystemCannabinoid Antagonists

Publications

Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance

Joseph Tam, Jie Liu, Grzegorz Godlewski et al. · Cell Metabolism · 2012 · 348 citations · Full text

Medicine, Endocrinology, Pharmacology +12

JD-5006 and JD-5037: Peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities

Robert J. Chorvat, Jennifer Berbaum, Kristine Seriacki et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 89 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis

Vijay P. Kale, Seth Gibbs, John Taylor et al. · Regulatory Toxicology and Pharmacology · 2019 · 25 citations · Full text

Medicine, Pharmacology, Toxicology +8

1–3 of 6

Authors

KS
Kristine Seriacki
Jenrin Discovery (United States), United States
2 publications · 89 citations
1
h-index

1–1 of 1